Literature DB >> 18287451

MR angiography of lower extremities at 3 T: presurgical planning of fibular free flap transfer for facial reconstruction.

Derek G Lohan1, Anderanik Tomasian, Mayil Krishnam, Praveen Jonnala, Keith E Blackwell, J Paul Finn.   

Abstract

OBJECTIVE: The purpose of our study was to evaluate the use of preoperative MR angiography of the lower extremities at 3 T in candidates for fibular free flap harvesting, identifying atherosclerotic occlusive disease and congenital anomalies in this population. Our intention was to document the influence of the imaging findings on the surgical approach used.
MATERIALS AND METHODS: Twenty-nine consecutive adult patients with facial abnormalities necessitating mandibular resection with subsequent osteocutaneous mandibular reconstruction who underwent preoperative MR angiography at 3 T were retrospectively reviewed. Images were evaluated by two observers with regard to image quality and visualization of arterial segments; severity of stenosis; and presence of noise, artifact, or venous contamination. The popliteal artery branching pattern present was also classified. The facial and reconstructive surgeon involved indicated whether the MR angiographic appearances influenced the decision regarding the side or location from which the flap was harvested or the flap design.
RESULTS: Arterial segments were visualized with good or excellent image quality in 722 of 725 segments for observer 1 and 721 segments for observer 2. The kappa coefficient indicated good interobserver agreement (kappa = 0.78) with regard to quality of arterial segment depiction and scoring of stenoocclusive disease (kappa = 0.64). No segments had venous contamination, noise, or artifact of a degree sufficient to compromise diagnostic interpretation. Imaging influenced the surgical approach in 16 (55.2%) of 29 patients.
CONCLUSION: Trifurcation vessel imaging should be a prerequisite to fibular free flap harvesting. High-spatial-resolution MR angiography at 3 T represents a desirable alternative to other invasive or cross-sectional imaging techniques in this regard.

Entities:  

Mesh:

Year:  2008        PMID: 18287451     DOI: 10.2214/AJR.07.2753

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  7 in total

1.  Peronea arteria magna.

Authors:  Lisa H Betz; Bradford W Betz
Journal:  Pediatr Radiol       Date:  2009-04-21

2.  Variations in the popliteal artery branching in 342 patients studied with peripheral CT angiography using 64-MDCT.

Authors:  Cuneyt Calisir; Sevtap Simsek; Murat Tepe
Journal:  Jpn J Radiol       Date:  2014-11-26       Impact factor: 2.374

3.  Variations of the popliteal artery branching with multidetector CT angiography.

Authors:  Bahar Yanik; Erdogan Bulbul; Gulen Demirpolat
Journal:  Surg Radiol Anat       Date:  2014-07-20       Impact factor: 1.246

4.  Time-resolved and bolus-chase MR angiography of the leg: branching pattern analysis and identification of septocutaneous perforators.

Authors:  Gurpreet S Sandhu; Rod P Rezaee; Katherine Wright; John A Jesberger; Mark A Griswold; Vikas Gulani
Journal:  AJR Am J Roentgenol       Date:  2010-10       Impact factor: 3.959

5.  Analysis of Variation in Anatomy of Lower Limb Vasculature and Implications for Free Fibula Flap by Color Doppler Imaging.

Authors:  Digwa Sunnysinh; Satyajit Dandagi; B C Sikkerimath; Anu Jose; Sushmit Priyam Bora
Journal:  J Maxillofac Oral Surg       Date:  2020-11-19

Review 6.  Life and Limb: Current Concepts in Endovascular Treatment of Extremity Trauma.

Authors:  John J Weaver; Jeffrey F B Chick; Eric J Monroe; Guy E Johnson
Journal:  Semin Intervent Radiol       Date:  2021-04-15       Impact factor: 1.513

7.  The congenital popliteal vasculature patterns in fibular free flap reconstruction by means of surgical anatomy in cadavers.

Authors:  Mathee Ongsiriporn; Piyawadee Jongpradubgiat; Sasiprapa Pisittrakoonporn; Natthapong Kongkunnavat; Kosin Panyaatisin; Nutcha Yodrabum
Journal:  Sci Rep       Date:  2021-10-01       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.